The Company's purpose is the sale of advanced automated insulin administration systems and related products that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company may acquire, hold, manage, operate, and transfer intellectual property rights both domestically and abroad, participate in other industrial and commercial enterprises, and may also open branches and establish subsidiaries both domestically and abroad. The Company may participate in group financing transactions, including by granting loans to its direct or indirect partners or other group companies, or by granting guarantees or other securities of any kind for their obligations to third parties, even if these loans or securities are in the exclusive interest of the Company's direct or indirect partners or other group companies or if they are provided free of charge. The Company may also engage in any transaction deemed appropriate to promote the Company's purpose.
Outbound Leads by COHAGA